Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Peckham, D.
Right arrow Articles by Ashman, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peckham, D.
Right arrow Articles by Ashman, R. F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 13, No. 3, 285-295, March 2001
© 2001 Japanese Society for Immunology

Difference in apoptosis induction between surface IgD and IgM

David Peckham1, Erica Andersen-Nissen2, Fred D. Finkelman3, Laura L. Stunz1 and Robert F. Ashman1,2

1 Department of Medicine, Iowa City Veterans Administration Medical Center, Iowa City, IA 52242, USA
2 University of Iowa College of Medicine, Iowa City, IA 52242, USA
3 Department of Medicine, University of Cincinnati College of Medicine and Cincinnati Veterans Administration Medical Center, Cincinnati, OH 45267, USA

Correspondence to: R. F. Ashman, Department of Medicine/Rheumatology, University of Iowa, C31-P GH, Iowa City, IA 52242 USA

In the classic `two-signal' model for B cell activation, signal 1 through the antigen receptor plus signal 2 through lymphokine receptors and CD40 leads to proliferation, but signal 1 alone leads to tolerance or anergy. In a protocol designed to deliver signal 1 in vitro with anti-{delta} without signal 2, purified small dense B cells from untreated mice exposed to any of three monoclonal anti-{delta} antibodies or to polyclonal anti-{delta} in vitro showed modest S phase entry at 50 µg/ml. In contrast, at low doses (0.1–0.5 µg/ml) of anti-{delta}, there was no cell cycle entry at 64 h, but apoptosis was accelerated at 16 h. Polyclonal anti-µ and three monoclonal anti-µs did not show this early apoptosis induction. Anti-CD40 and IL-4 inhibited apoptosis in B cells treated with 0.5 µg/ml anti-{delta} and increased S phase entry at 10 µg/ml anti-{delta}. Low-dose anti-{delta} (but not anti-µ) induced increased B7-2 and class II MHC expression on a subset of B cells, many of which were in apoptosis. Larger transient increases in c-Myc and Egr-1 expression were seen with low-dose anti-{delta} than with anti-µ, followed by an abrupt fall below baseline, a sequence previously linked to apoptosis. There was no change in Bcl-2, Bcl-xL or Bax. These data suggest a functional difference between {delta} and µ cross-linking on resting spleen B cells. A BCR stimulus sufficient for early activation events, but insufficient for full G1 entry, may lead to apoptosis.

Keywords: anti-{delta}, apoptosis, B lymphocytes, cell cycle entry, spleen

Transmitting editor: J. Banchereau


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
E. V. Acosta Rodriguez, E. Zuniga, C. L. Montes, and A. Gruppi
Interleukin-4 biases differentiation of B cells from Trypanosoma cruzi-infected mice and restrains their fratricide: role of Fas ligand down-regulation and MHC class II-transactivator up-regulation
J. Leukoc. Biol., January 1, 2003; 73(1): 127 - 136.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.